Chris Lange

Chris Lange is an analyst for 24/7 Wall St., based in Houston. He has covered financial markets over the past five years with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and has helped start a small business.

Lastest Stories by Chris Lange

Why Analysts Are Taking Mixed Stances on These 2 Megabanks
The tale of the tape was drastically different when JPMorgan and Wells Fargo reported quarterly results, and this was reflected somewhat in what analysts are saying about them after the fact.
Chris Lange
11 hours ago

Immutep Makes Big Claim to COVID-19 Antibody Patent
Immutepjoins the ever-growing list of coronavirus stocks by announcing that it was granted a patent related to COVID-19 antibodies.
Chris Lange
12 hours ago

Moderna's Next Big Step in the Race to a COVID-19 Vaccine
Moderna made another big step forward in the fight against COVID-19 after the company reported incredibly positive data from the early-stage trial of its coronavirus vaccine.
Chris Lange
13 hours ago

Why UnitedHealth's Massive Bottom-Line Beat Doesn't Matter
UnitedHealth Group released mixed second-quarter financial results and maintained its guidance before the markets opened on Wednesday.
Chris Lange
13 hours ago

6 Warren Buffett Stocks That Could Soar as 2021 Approaches
24/7 Wall St. looks at some potential winners among Warren Buffett’s holdings. See why they could rally headed toward 2021 and beyond.
Chris Lange
16 hours ago

Canadian Biotech Firm Sees Major Upside in COVID-19 Study
IMV shares surged on Tuesday after the company provided an update on its vaccine candidate for COVID-19.
Chris Lange
1 day ago

American Airlines Set to Join in Pilot Layoffs
American Airlines may be joining the list of companies that are furloughing employees during this coronavirus pandemic.
Chris Lange
1 day ago

What Does $1.7 Billion Mean to Blueprint Medicines?
Blueprint Medicines announced early on Tuesday that it had entered into a global collaboration with pharmaceutical giant Roche in which it may receive up to $1.7 billion.
Chris Lange
1 day ago

Citigroup's Incredible Fixed Income Growth Is Not Good Enough?
Citigroup reported better than expected second-quarter financial results before the markets opened on Tuesday.
Chris Lange
1 day ago

Wells Fargo Earnings Catch a Bad Case of COVID-19
Wells Fargo released a disappointing second-quarter earnings report and lowered its dividend before the opening bell on Tuesday.
Chris Lange
1 day ago

9 Top Tech Stocks Are Coronavirus Winners and Overvalued
24/7 Wall St. has picked out a handful of stocks that are the biggest winners from the pandemic thus far. Analysts are incredibly bullish on them all.
Chris Lange
1 day ago

COVID-19 Testing Creates a Boom for LabCorp and Quest Diagnostics
One of the most important aspects of reopening the economy during this pandemic is testing for COVID-19. Credit Suisse sees a couple of winners benefitting incredibly from this.
Chris Lange
2 days ago

Even More Optimism for COVID-19 Vaccines as 2 More Hit the Fast Track
Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus vaccine candidates received Fast Track Designation.
Chris Lange
2 days ago

Lockdown Snacking Keeps PepsiCo Afloat
PepsiCo reported better than expected most recent quarterly results before the markets opened on Monday but noted that its fiscal 2020 guidance is no longer applicable.
Chris Lange
2 days ago

Short Sellers Can't Make Up Their Minds on Big Biotechs
The June 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
2 days ago